Cited 0 times in Scipus Cited Count

Pulmonary Surfactants: a New Therapeutic Target in Asthma

DC Field Value Language
dc.contributor.authorChoi, Y-
dc.contributor.authorJang, J-
dc.contributor.authorPark, HS-
dc.date.accessioned2022-10-24T05:53:48Z-
dc.date.available2022-10-24T05:53:48Z-
dc.date.issued2020-
dc.identifier.issn1529-7322-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/22388-
dc.description.abstractPURPOSE OF REVIEW: Lung tissues are highly susceptible to airway inflammation as they are inevitably exposed to inhaled pathogens and allergens. In the lungs, clearance of infectious agents and regulation of inflammatory responses are important for the first-line defense, where surfactants play a role in host defense mechanisms. In this review, clinical significance of pulmonary surfactants in asthma has been highlighted.

RECENT FINDINGS: Surfactants, such as surfactant protein A (SP-A) and SP-D released from alveolar epithelium, reduce pathogen infection and control immune-cell activation. Especially, SP-D directly binds to eosinophil surface, leading to inhibition of extracellular trap formation and reduction in airway inflammation. Production of surfactants is commonly determined by both genetic (single nucleotide polymorphisms) and environmental factors influencing processes involved in the development of asthma. In addition, nintedanib (an intracellular inhibitor of tyrosine kinases) could increase SP-D levels and is used in patients with idiopathic pulmonary fibrosis. These findings may provide a possible application of SP-D in asthma. Surfactants are key players contributing to host defense through maintaining the immune system. As clinical implications of surfactants involved in asthma have been suggested, further translational studies are needed to apply surfactants as an effective therapeutic target in patients with asthma.
-
dc.language.isoen-
dc.subject.MESHAsthma-
dc.subject.MESHHumans-
dc.subject.MESHPulmonary Surfactants-
dc.titlePulmonary Surfactants: a New Therapeutic Target in Asthma-
dc.typeArticle-
dc.identifier.pmid32914349-
dc.identifier.urlhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7483065/-
dc.subject.keywordAirway inflammation-
dc.subject.keywordAsthma-
dc.subject.keywordEosinophil-
dc.subject.keywordEpithelium-
dc.subject.keywordSurfactant-
dc.subject.keywordTherapy-
dc.contributor.affiliatedAuthorChoi, Y-
dc.contributor.affiliatedAuthorJang, J-
dc.contributor.affiliatedAuthorPark, HS-
dc.type.localJournal Papers-
dc.identifier.doi10.1007/s11882-020-00968-8-
dc.citation.titleCurrent allergy and asthma reports-
dc.citation.volume20-
dc.citation.number11-
dc.citation.date2020-
dc.citation.startPage70-
dc.citation.endPage70-
dc.identifier.bibliographicCitationCurrent allergy and asthma reports, 20(11). : 70-70, 2020-
dc.identifier.eissn1534-6315-
dc.relation.journalidJ015297322-
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Allergy
Files in This Item:
32914349.pdfDownload

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse